Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Early Phase 1
2(66.7%)
Phase 2
1(33.3%)
3Total
Early Phase 1(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06722898Phase 2Not Yet Recruiting

Rapid BAC Reduction with Nutraceutical Blend Study

Role: lead

NCT06417983Not Yet Recruiting

Topical Application of Essential Oils to Treat Onchomycosis

Role: lead

NCT06003062Unknown

Suppression of Upper Lip Hair Growth Using Novel Hemp Extract

Role: lead

NCT05734703Early Phase 1Unknown

Skin Rejuvenation With Topical Extract and Other Nutraceuticals

Role: lead

NCT05574049Early Phase 1Completed

Weight Loss, Blood Sugar and Blood Lipid Effects of Tetrahydrocannabivarin (THCV) Impregnated Mucoadhesive Strips

Role: lead

All 5 trials loaded